Seneschal Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Seneschal Advisors's BMY Position: Q1 2026 in Review
Seneschal Advisors increased its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, buying an estimated $233 and bringing the position to 24 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #196.
Seneschal Advisors first reported a position in BMY in Q3 2025 and has held it in 3 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Seneschal Advisors held 24 shares of Bristol-Myers Squibb worth $1.46K as of Q1 2026.
- Seneschal Advisors bought 4 Bristol-Myers Squibb shares in Q1 2026, an estimated $233.
- Bristol-Myers Squibb made up ﹤0.01% of Seneschal Advisors's portfolio in Q1 2026, its #196 holding.
- Seneschal Advisors first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 3 quarters since.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Seneschal Advisors's 13F filing for Q1 2026, filed 8 May 2026.